CRDF Stock Surges on Latest Medical Research Breakthrough
Cardiff Oncology Inc. saw its stock soar 52.46% on December 10, 2025. This surge was fueled by a groundbreaking medical research discovery. The breakthrough could revolutionize cancer treatment research1. The company secured a U.S. patent for a new colorectal cancer treatment. This patent combines onvansertib with bevacizumab. It provides protection until 2043, marking a major…